Impact of Dupilumab on Quality of Life for Atopic Dermatitis Patients
Expert dermatologists review the positive impact dupilumab has on quality of life for a patient with atopic dermatitis.
Efficacy and Reported Outcomes With JAK Inhibitors in Atopic Dermatitis
Experts in dermatology discuss efficacy and patient-reported outcomes of topical and systemic JAK inhibitors and dosing guidelines in atopic dermatitis.
Ideal Candidates for Ruxolitinib Treatment of Atopic Dermatitis
Matthew Zirwas, MD, provides insight into the ideal candidates for use of ruxolitinib to treat atopic dermatitis, focusing on patients with sensitive skin.
Safety Profile of Topical Ruxolitinib in Atopic Dermatitis
Expert dermatologists review the safety data of topical ruxolitinib in the treatment of atopic dermatitis.
Clinical Trials of Topical Ruxolitinib in Atopic Dermatitis
Alexandra Golant, MD, highlights the positive clinical data of ruxolitinib, a topical JAK inhibitor used for the treatment of atopic dermatitis.
Overview of JAK Inhibitors in Atopic Dermatitis
Peter A. Lio, MD, provides an overview of emerging JAK inhibitors in the treatment of atopic dermatitis.
Assessing Severity of Atopic Dermatitis
Experts in dermatology consider the use of the Atopic Dermatitis Control Tool and other tools to assess severity of atopic dermatitis.
Treatment Approach to Atopic Dermatitis
Aaron S. Farberg, MD, discusses how new therapies have impacted his approach to treatment of atopic dermatitis.
Traditional Steroids vs Emerging Therapies in Atopic Dermatitis
Alexandra Golant, MD, comments on the adverse events of systemic therapies and how emerging nonsteroidal agents have a better safety profile in atopic dermatitis.
Treatment Landscape in Atopic Dermatitis
Matthew Zirwas, MD, highlights therapies that are available for the treatment of atopic dermatitis, including corticosteroids, calcineurin inhibitors and JAK inhibitors.
The Impact of Atopic Dermatitis on Quality of Life
Expert dermatologists review the impact of atopic dermatitis on quality of life for both the patient and their families.
An Overview of Atopic Dermatitis (AD)
Peter A. Lio, MD, provides an overview of the pathophysiology of atopic dermatitis (AD) and the comorbidities often associated with it.
Keeping Physicians Up to Date With AD Advances
Experts in dermatology share advice on helping fellow physicians stay apprised of the advances in AD and treat their patients more effectively.
Emerging Treatment Options in AD
Expert dermatologists consider ongoing trials and emerging treatment options for the management of AD.
Guidance for Topical Treatment Use Based on BSA in AD
Experts in dermatology share general guidance for use of topicals, switching from topical to systemic treatment, and when combination therapy is an option for patients with atopic dermatitis.
Monitoring AD Treatments in Various Age Groups
Omar Noor, MD, and Adelaide A. Hebert, MD, discuss monitoring requirements for various classes of treatments in atopic dermatitis, including topical vs systemic.
Treatment Options for Patients With Moderate Disease Over 10%-20% BSA
Peter A. Lio, MD, reviews treatment options for patients with moderate AD.
Treatment Goals in AD
Matthew Zirwas, MD, shares goals of therapy for a patient with AD.
Implications of Boxed Warnings of Topical JAK inhibitors
Expert dermatologists address the clinical implications of boxed warnings of topical treatments in AD.
Time to Response in AD
Matthew Zirwas, MD, and Omar Noor, MD, comment on their own experience of time to response with topical and systemic treatments of AD.
Durability of Response to Treatment in AD
Peter A. Lio, MD, discusses the durability of topical treatments in AD, including steroids, calcineurin inhibitors, and JAK inhibitors.
Efficacy Data for Topical Treatment of AD
Experts discuss long-term efficacy data for topical medications for the treatment of AD.
Patient With Limited Disease Activity in AD
Matthew Zirwas, MD, and Omar Noor, MD, review a patient scenario where AD disease activity is limited but in difficult to treat locations.
AD Treatment Options for Patients Moving Away from Long-Term Steroids
Peter A. Lio, MD, shares his approach to presenting treatment alternatives to patients who want to stop using long-term steroids for treatment of AD.
Challenges Faced by Non-Dermatologists When Using Steroids
Adelaide A. Hebert, MD, comments on the need for nondermatologist education on the basics of skin disease care.
Durability of Topical Steroid Use in AD
Expert dermatologists discuss the durability of long-term use of topical steroids for treatment of atopic dermatitis.
Patient on Long-Term Steroidal Use in AD
Adelaide A. Hebert, MD, reviews the use of long-term steroids for treatment of atopic dermatitis.
Factors Guiding Treatment Selection in AD
Experts in dermatology discuss which disease characteristics play the biggest role in influencing treatment choice or change of treatment from the perspective of a patient with atopic dermatitis.
Treatment Options and Targets in Atopic Dermatitis (AD)
A panel of expert dermatologists comments on newly approved and traditional treatment options, addressing how they target inflammation and the pathophysiology of atopic dermatitis (AD).
The Importance of Patient Education in Atopic Dermatitis Management
Experts in dermatology stress the importance of patient education in atopic dermatitis management and discuss their approaches to keeping patients up-to date.
2 Clarke Drive Cranbury, NJ 08512